Selected article for: "AA arachidonic acid and agonist ADP"

Title: 2016 ACVIM Forum Research Abstract Program
  • Document date: 2016_5_31
  • ID: 2y1y8jpx_375
    Snippet: Six dogs were given ASA 1 mg/kg/day and placebo, clopidogrel 2 mg/kg/day and placebo, or a combination of both drugs, for 1 week each. Drugs were given in a randomized crossover design (Latin square). Each dog was randomized to one of the three treatments in three different phases such that each dog received each treatment. Investigators were blinded to the treatments. A washout period of 2 weeks occurred between phases. Blood samples were collec.....
    Document: Six dogs were given ASA 1 mg/kg/day and placebo, clopidogrel 2 mg/kg/day and placebo, or a combination of both drugs, for 1 week each. Drugs were given in a randomized crossover design (Latin square). Each dog was randomized to one of the three treatments in three different phases such that each dog received each treatment. Investigators were blinded to the treatments. A washout period of 2 weeks occurred between phases. Blood samples were collected on days 0 and 7 of each phase, and analyzed using MP (adenosine diphosphate [ADP], arachidonic acid [AA], collagen [COL] agonists), PFA (P2Y, COL-ADP, COL-Epinephrine [EPI] cartridges), and PW (ADP, AA, COL agonist tubes) using the two hematology analyzers.

    Search related documents:
    Co phrase search for related documents
    • AA arachidonic acid and ADP adenosine diphosphate: 1, 2, 3, 4, 5, 6, 7
    • AA arachidonic acid and arachidonic acid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adenosine diphosphate and ADP adenosine diphosphate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adenosine diphosphate and arachidonic acid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • ADP adenosine diphosphate and arachidonic acid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • arachidonic acid and kg day: 1, 2, 3
    • blood sample and different phase: 1
    • blood sample and hematology analyzer: 1
    • crossover design and kg day: 1, 2
    • different phase and drug combination: 1, 2
    • different phase treatment and drug combination: 1